PROPHASE LABS INC (PRPH) Stock Price, Quote, News and Overview
NASDAQ:PRPH - Nasdaq - US74345W1080 - Common Stock - Currency: USD
PRPH Quote, Performance and Key Statistics
PROPHASE LABS INC
NASDAQ:PRPH (1/31/2025, 8:00:00 PM)
After market: 0.3382 +0.07 (+28.45%)0.2633
-0.16 (-38.02%)
The current stock price of PRPH is 0.2633 USD. In the past month the price decreased by -65.22%. In the past year, price decreased by -94.82%.
PRPH Latest News, Press Releases and Analysis
Which stocks are moving after the closing bell on Friday?
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
What's going on in today's session
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm
Transaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances the Company’s...
PRPH Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 79.75 | 769.97B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.43 | 375.07B | ||
| JNJ | JOHNSON & JOHNSON | 15.23 | 366.32B | ||
| MRK | MERCK & CO. INC. | 16.61 | 249.98B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.57 | 219.43B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.04 | 209.36B | ||
| PFE | PFIZER INC | 10.28 | 150.29B | ||
| SNY | SANOFI-ADR | 14.85 | 136.24B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.38 | 119.56B | ||
| ZTS | ZOETIS INC | 29.67 | 77.10B | ||
| GSK | GSK PLC-SPON ADR | 8.5 | 71.96B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 22.32 | 42.45B |
Related stock screener links
About PRPH
Company Profile
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. The company is headquartered in New York City, New York and currently employs 113 full-time employees. The firm provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its segments include diagnostic services and consumer products. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. Its CLIA labs and diagnostic technology provide wellness solutions.
Company Info
PROPHASE LABS INC
711 Stewart Ave, Suite 200, Garden City
New York City NEW YORK 11530 US
CEO: Ted Karkus
Employees: 113
Company Website: https://www.prophaselabs.com/
Investor Relations: http://www.prophaselabs.com/investors/annual-reports/
Phone: 12153450919
PRPH FAQ
What is the stock price of PRPH?
The current stock price of PRPH is 0.2633 USD.
What is the symbol for PROPHASE LABS INC stock?
The exchange symbol of PROPHASE LABS INC is PRPH and it is listed on the Nasdaq exchange.
On which exchange is PRPH stock listed?
PRPH stock is listed on the Nasdaq exchange.
Is PRPH a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for PRPH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of PRPH.
Does PRPH stock pay dividends?
PRPH does not pay a dividend.
What is the Price/Earnings (PE) ratio of PRPH?
PRPH does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.26).
What is the Short Interest ratio of PRPH stock?
The outstanding short interest for PRPH is 0.48% of its float.
PRPH Technical Analysis
PRPH Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PRPH. Both the profitability and financial health of PRPH have multiple concerns.
PRPH Financial Highlights
Over the last trailing twelve months PRPH reported a non-GAAP Earnings per Share(EPS) of -1.26. The EPS decreased by -113.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.23% | ||
| ROE | -72.8% | ||
| Debt/Equity | 0.29 |
PRPH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to PRPH. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 36.51% and a revenue growth 15.53% for PRPH